Clinical trials: Idiopathic Recurrent Pericarditis
Idiopathic Recurrent Pericarditis
Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis
The goal of this clinical trial is to evaluate the safety and efficacy of RPH-104 for long-term use in a population of patients with idiopathic recurrent pericarditis who completed the main study CL04018068.
- Trial name
- NCT05673902
- Testing
- RPH-104
- Where
- Russia
- Volunteers
- 17 people
- Sponsor
- R-Pharm International, LLC
Pericarditis Idiopathic Recurrent
Hydroxychloroquine in Colchicine-Resistant Glucocorticoid-Dependent Idiopathic Recurrent Pericarditis
Among patients with colchicine-resistant glucocorticoid-dependent idiopathic RP (idiopathic recurrent pericarditis during at least a second recurrence, having met the 2015 European Society of Cardiology criteria for pericarditis…
- Trial name
- RESTORE (NCT05737680)
- Testing
- Hydroxychloroquine, Colchicine
- Where
- Greece
- Volunteers
- 30 people
- Sponsor
- Hippocration General Hospital
Idiopathic Recurrent Pericarditis
Pericarditis: Auto-Inflammation in Recurrent Disease
Pericarditis is swelling of the sac that surrounds the heart, the pericardium, causing chest pain. For most patients, the condition improves with simple anti-inflammatory medications like colchicine and ibuprofen.
- Trial name
- PAIReD (NCT04996108)
- Where
- 2 sites in United Kingdom
- Volunteers
- 119 people, healthy volunteers welcome
- Sponsor
- King's College London
Idiopathic Recurrent Pericarditis
AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP)
Recent findings suggest that recurrent pericarditis (RP) may be a previously unrecognized autoinflammatory disease. The pivotal pathogenic role of interleukin (IL)-1 in RP has been shown by the achievement of complete responses…
- Trial name
- AIR TRIP (NCT02219828)
- Testing
- Anakinra
- Where
- 3 sites in Italy
- Volunteers
- 21 people
- Sponsor
- Massimo Imazio